BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25343957)

  • 1. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
    Gambacorti-Passerini CB; Donadoni C; Parmiani A; Pirola A; Redaelli S; Signore G; Piazza V; Malcovati L; Fontana D; Spinelli R; Magistroni V; Gaipa G; Peronaci M; Morotti A; Panuzzo C; Saglio G; Usala E; Kim DW; Rea D; Zervakis K; Viniou N; Symeonidis A; Becker H; Boultwood J; Campiotti L; Carrabba M; Elli E; Bignell GR; Papaemmanuil E; Campbell PJ; Cazzola M; Piazza R
    Blood; 2015 Jan; 125(3):499-503. PubMed ID: 25343957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
    Piazza R; Valletta S; Winkelmann N; Redaelli S; Spinelli R; Pirola A; Antolini L; Mologni L; Donadoni C; Papaemmanuil E; Schnittger S; Kim DW; Boultwood J; Rossi F; Gaipa G; De Martini GP; di Celle PF; Jang HG; Fantin V; Bignell GR; Magistroni V; Haferlach T; Pogliani EM; Campbell PJ; Chase AJ; Tapper WJ; Cross NC; Gambacorti-Passerini C
    Nat Genet; 2013 Jan; 45(1):18-24. PubMed ID: 23222956
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Iaquinta G; Scalzulli E; Angeloni S; Carmosino I; Costa A; Ielo C; Passucci M; Masucci C; Martelli M; Grammatico P; Breccia M
    Leuk Lymphoma; 2023 Oct; 64(10):1730-1732. PubMed ID: 37435984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical CML: diagnosis and treatment.
    Breccia M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
    Lasho TL; Finke CM; Zblewski D; Patnaik M; Ketterling RP; Chen D; Hanson CA; Tefferi A; Pardanani A
    Blood Cancer J; 2015 Jan; 5(1):e275. PubMed ID: 25615281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Classification and Prognosis in Acute Myeloid Leukemia.
    Papaemmanuil E; Gerstung M; Bullinger L; Gaidzik VI; Paschka P; Roberts ND; Potter NE; Heuser M; Thol F; Bolli N; Gundem G; Van Loo P; Martincorena I; Ganly P; Mudie L; McLaren S; O'Meara S; Raine K; Jones DR; Teague JW; Butler AP; Greaves MF; Ganser A; Döhner K; Schlenk RF; Döhner H; Campbell PJ
    N Engl J Med; 2016 Jun; 374(23):2209-2221. PubMed ID: 27276561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
    Metzeler KH; Herold T; Rothenberg-Thurley M; Amler S; Sauerland MC; Görlich D; Schneider S; Konstandin NP; Dufour A; Bräundl K; Ksienzyk B; Zellmeier E; Hartmann L; Greif PA; Fiegl M; Subklewe M; Bohlander SK; Krug U; Faldum A; Berdel WE; Wörmann B; Büchner T; Hiddemann W; Braess J; Spiekermann K;
    Blood; 2016 Aug; 128(5):686-98. PubMed ID: 27288520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of ETNK1 in aCML and CMML.
    Kosmider O
    Blood; 2015 Jan; 125(3):422-3. PubMed ID: 25593331
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of mutation order on myeloproliferative neoplasms.
    Ortmann CA; Kent DG; Nangalia J; Silber Y; Wedge DC; Grinfeld J; Baxter EJ; Massie CE; Papaemmanuil E; Menon S; Godfrey AL; Dimitropoulou D; Guglielmelli P; Bellosillo B; Besses C; Döhner K; Harrison CN; Vassiliou GS; Vannucchi A; Campbell PJ; Green AR
    N Engl J Med; 2015 Feb; 372(7):601-612. PubMed ID: 25671252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated molecular analysis of adult T cell leukemia/lymphoma.
    Kataoka K; Nagata Y; Kitanaka A; Shiraishi Y; Shimamura T; Yasunaga J; Totoki Y; Chiba K; Sato-Otsubo A; Nagae G; Ishii R; Muto S; Kotani S; Watatani Y; Takeda J; Sanada M; Tanaka H; Suzuki H; Sato Y; Shiozawa Y; Yoshizato T; Yoshida K; Makishima H; Iwanaga M; Ma G; Nosaka K; Hishizawa M; Itonaga H; Imaizumi Y; Munakata W; Ogasawara H; Sato T; Sasai K; Muramoto K; Penova M; Kawaguchi T; Nakamura H; Hama N; Shide K; Kubuki Y; Hidaka T; Kameda T; Nakamaki T; Ishiyama K; Miyawaki S; Yoon SS; Tobinai K; Miyazaki Y; Takaori-Kondo A; Matsuda F; Takeuchi K; Nureki O; Aburatani H; Watanabe T; Shibata T; Matsuoka M; Miyano S; Shimoda K; Ogawa S
    Nat Genet; 2015 Nov; 47(11):1304-15. PubMed ID: 26437031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
    Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
    Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related mutations and chronic myelomonocytic leukemia.
    Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
    Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
    Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
    N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
    Nones K; Waddell N; Wayte N; Patch AM; Bailey P; Newell F; Holmes O; Fink JL; Quinn MCJ; Tang YH; Lampe G; Quek K; Loffler KA; Manning S; Idrisoglu S; Miller D; Xu Q; Waddell N; Wilson PJ; Bruxner TJC; Christ AN; Harliwong I; Nourse C; Nourbakhsh E; Anderson M; Kazakoff S; Leonard C; Wood S; Simpson PT; Reid LE; Krause L; Hussey DJ; Watson DI; Lord RV; Nancarrow D; Phillips WA; Gotley D; Smithers BM; Whiteman DC; Hayward NK; Campbell PJ; Pearson JV; Grimmond SM; Barbour AP
    Nat Commun; 2014 Oct; 5():5224. PubMed ID: 25351503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
    Patnaik MM; Barraco D; Lasho TL; Finke CM; Reichard K; Hoversten KP; Ketterling RP; Gangat N; Tefferi A
    Am J Hematol; 2017 Jun; 92(6):542-548. PubMed ID: 28314085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
    Ohgami RS; Ma L; Merker JD; Gotlib JR; Schrijver I; Zehnder JL; Arber DA
    Mod Pathol; 2015 May; 28(5):706-14. PubMed ID: 25412851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
    Ramos F; Robledo C; Izquierdo-García FM; Suárez-Vilela D; Benito R; Fuertes M; Insunza A; Barragán E; Del Rey M; García-Ruiz de Morales JM; Tormo M; Salido E; Zamora L; Pedro C; Sánchez-Del-Real J; Díez-Campelo M; Del Cañizo C; Sanz GF; Hernández-Rivas JM;
    Oncotarget; 2016 May; 7(21):30492-503. PubMed ID: 27127180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol.
    Bolli N; Manes N; McKerrell T; Chi J; Park N; Gundem G; Quail MA; Sathiaseelan V; Herman B; Crawley C; Craig JI; Conte N; Grove C; Papaemmanuil E; Campbell PJ; Varela I; Costeas P; Vassiliou GS
    Haematologica; 2015 Feb; 100(2):214-22. PubMed ID: 25381129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
    Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
    Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.